Sera Prognostics
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 57
- Market Cap
- -
- Introduction
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
- Conditions
- Preterm BirthPreterm Labor
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Sera Prognostics, Inc.
- Target Recruit Count
- 6500
- Registration Number
- NCT04301518
- Locations
- 🇺🇸
UCSD, San Diego, California, United States
🇺🇸Yale, New Haven, Connecticut, United States
🇺🇸Delaware/Christiana Care, Newark, Delaware, United States
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
- Conditions
- Preterm Birth
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Sera Prognostics, Inc.
- Target Recruit Count
- 5011
- Registration Number
- NCT02787213
- Locations
- 🇺🇸
Maricopa Integrated Health Systems, Phoenix, Arizona, United States
🇺🇸University of California, Irvine Medical Center, Orange, California, United States
🇺🇸UC San Diego Health, San Diego, California, United States
Proteomic Assessment of Preterm Birth
- Conditions
- Preterm Birth
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- Sera Prognostics, Inc.
- Target Recruit Count
- 5500
- Registration Number
- NCT01371019
- Locations
- 🇺🇸
Maricopa Integrated Health System, Phoenix, Arizona, United States
🇺🇸San Diego Perinatal Clinic, San Diego, California, United States
🇺🇸Christiana Care Health System, Newark, Delaware, United States
News
Sera Prognostics to Present at TD Cowen Conference and Report Q1 2025 Results in May
Sera Prognostics, focused on maternal and neonatal health through pregnancy biomarker testing, will present at the TD Cowen 45th Annual Health Care Conference on March 5, 2025, with CEO Zhenya Lindgardt providing company updates.